Amy Hallman Rice has a general corporate transactional practice, and represents both privately-held and public companies in a wide range of transactions. Amy also has more than 16 years of experience in bankruptcy and insolvency law.
MannKind Announces up to $200 Million Royalty Purchase Agreement With Sagard Healthcare
January 2, 2024
Cooley advised MannKind, a company focusing on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases, on the sale of a 1% royalty in net sales of Tyvaso DPI (treprostinil) inhalation powder to Sagard Healthcare for up to $200 million.
CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion
January 10, 2023
Cooley advised CinCor Pharma, a clinical-stage biopharmaceutical company, on its definitive agreement to be acquired by AstraZeneca. M&A partners Rama Padmanabhan and Rowook Park and corporate partners Div Gupta and Sarah Sellers led the Cooley team.
Cooley advised Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, on its agreement to sell to Sanofi for approximately $2.5 billion. Partners Barbara Borden, Rama Padmanabhan and Ken Rollins led the Cooley team.